Episode 17: Appen’s acquisition, Advance NanoTek, Clinuval Pharmaceuticals and more!

The LaserBond (ASX:LBL) share price rose 11% on Tuesday following announcements of positive revenue and profit forecasts from the company. What does LaserBond do? Founded in 1992, Laserbond is a specialist surface engineering company that focuses on the development and application of materials, technologies and methodologies to increase operating performance and life of capital-intensive machinery components. LaserBond states that its […]

The concept of ‘value’ is core to investing. At one level, it’s a relatively straightforward idea, and one we intuitively understand. As investors, we are, essentially, trying to buy assets for less than what they are “really” worth. For us, the value is captured when the wider market recognises and corrects the mispricing. But there’s also value in something that is (somehow) perfectly […]

There’s no surer deflator of markets as uncertainty. It’s the key ingredient to any bear market; the more there is, the sharper the falls. That’s why the coronavirus is wreaking such havoc. No one really knows how far it will spread, how many deaths it will cause and how long it will last. The potential economic impact ranges from ‘sharp […]

A first mover in technology, Webjet is looking to further improve margins with blockchain tech

Is now a good time to buy?

By themselves, stock tips are largely worthless…

We love our small caps here at Strawman. And not without good reason. The trouble is, at least according to conventional wisdom, that things are far riskier in that space. Perhaps that’s true, to some extent, if by risk you mean volatility. And it’s not an unfair characterisation if you assume, as many do, that “small cap” must mean pre-revenue, […]

With shares up around 48 times in the past four years, is there still any upside to be had?